Outcomes of neovascular glaucoma in eyes presenting with moderate to good visual potential
- PMID: 33745037
- DOI: 10.1007/s10792-021-01789-y
Outcomes of neovascular glaucoma in eyes presenting with moderate to good visual potential
Abstract
Purpose: To compare the disease characteristics and treatment outcomes of patients with neovascular glaucoma (NVG) presenting with visual acuity (VA) 6/60 or better in two different health systems.
Methods: Retrospective chart review of consecutive patients with NVG who presented between January 2016 to January 2018 in 5 tertiary-centres in India and one eye-specialist centre in London (UK) was performed. The baseline characteristics, treatment provisions, and visual outcomes in the India and UK cohorts were compared.
Results: At presentation, 18% (83 of 451) and 22% (59 of 270) of patients with NVG had VA 6/60 or better in India and the UK cohorts, respectively. The aetiologies of NVG were similar with proliferative diabetic retinopathy being the most common cause (60.9%, India; 64.4%, UK; p = 0.38). Previous panretinal photocoagulation was more prevalent in the UK cohort compared to the India cohort (94.9% versus 66.3%, respectively; p < 0.001). The mean number of intravitreal anti-VEGF injections per eye was higher in the Indian cohort (1.65 ± 0.97 versus 1.14 ± 1.02 injections; p < 0.001). The number of eyes with closed angles (36.9% India versus 30.5% UK; p = 0.45) and the number of eyes needing glaucoma interventions (52.1% India; 62.7% UK; p = 0.82) were similar in two cohorts. Among glaucoma surgeries, trabeculectomies were more commonly performed in the Indian cohort (23 vs 4; p < 0.001),while glaucoma drainage device surgeries were more prevalent in the UK cohort (18 vs 4 p < 0.001). After a median follow-up of 21 months (IQR 8.4-34.8 India; 24-36 months UK), favourable visual outcomes (vision stable or improved) were similar in both health systems (52.5% in the Indian cohort vs 43.4% in the UK cohort; p = 0.28). On multivariate regression analysis, the need for trans-scleral cyclophotocoagulation was associated with worse visual outcomes in both cohorts.
Conclusions: The causes and clinical profile of neovascular glaucoma with presenting visual acuity 6/60 or better in India and the UK were similar. Only up to 50% of eyes achieved favourable visual outcomes with current management protocols in both health systems.
Keywords: Neovascular glaucoma; Outcomes; Visual potential.
Similar articles
-
Visual Outcomes in Eyes With Neovascular Glaucoma and Anterior Segment Neovascularization Without Glaucoma.Am J Ophthalmol. 2022 Apr;236:1-11. doi: 10.1016/j.ajo.2021.09.006. Epub 2021 Sep 23. Am J Ophthalmol. 2022. PMID: 34562418
-
Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.Eye (Lond). 2016 Mar;30(3):463-72. doi: 10.1038/eye.2015.259. Epub 2015 Dec 18. Eye (Lond). 2016. PMID: 26681145 Free PMC article.
-
Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma.Graefes Arch Clin Exp Ophthalmol. 2013 May;251(5):1355-60. doi: 10.1007/s00417-012-2236-9. Epub 2012 Dec 19. Graefes Arch Clin Exp Ophthalmol. 2013. PMID: 23250484
-
A review of neovascular glaucoma. Etiopathogenesis and treatment.Rom J Ophthalmol. 2021 Oct-Dec;65(4):315-329. doi: 10.22336/rjo.2021.66. Rom J Ophthalmol. 2021. PMID: 35087972 Free PMC article. Review.
-
Neovascular glaucoma: a retrospective review from a tertiary center in China.BMC Ophthalmol. 2016 Jan 27;16:14. doi: 10.1186/s12886-016-0190-8. BMC Ophthalmol. 2016. PMID: 26818828 Free PMC article. Review.
Cited by
-
Effect of combined therapy based on transscleral peripheral retinal cryotherapy in the treatment of open-angle neovascular glaucoma: a retrospective study.BMC Ophthalmol. 2025 Jul 1;25(1):375. doi: 10.1186/s12886-025-04185-7. BMC Ophthalmol. 2025. PMID: 40597872 Free PMC article.
-
Widefield swept-source optical coherence tomography angiography metrics associated with neovascular glaucoma in patients with proliferative diabetic retinopathy.Graefes Arch Clin Exp Ophthalmol. 2024 Apr;262(4):1111-1120. doi: 10.1007/s00417-023-06290-z. Epub 2023 Nov 14. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 37962666
-
A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment.Medicina (Kaunas). 2022 Dec 18;58(12):1870. doi: 10.3390/medicina58121870. Medicina (Kaunas). 2022. PMID: 36557072 Free PMC article. Review.
-
Trabeculectomy for neovascular glaucoma in proliferative diabetic retinopathy, central retinal vein occlusion, and ocular ischemic syndrome: Surgical outcomes and prognostic factors for failure.Indian J Ophthalmol. 2021 Nov;69(11):3341-3348. doi: 10.4103/ijo.IJO_1516_21. Indian J Ophthalmol. 2021. PMID: 34708802 Free PMC article.
References
-
- Havens SJ, Gulati V (2016) Neovascular glaucoma. Dev Ophthalmol 55:196–204. https://doi.org/10.1159/000431196 - DOI - PubMed
-
- Rodrigues GB, Abe RY, Zangalli C, Sodre SL, Donini FA, Costa DC, Leite A, Felix JP, Torigoe M, Diniz-Filho A (2016) Neovascular glaucoma: a review. Int J retina vitre 2(1):26 - DOI
-
- Nielsen NV (1983) The prevalence of glaucoma and ocular hypertension in type 1 and 2 diabetes mellitus: an epidemiological study of diabetes mellitus on the island of Falster. Denmark Acta ophthalmologica 61(4):662–672 - DOI
-
- Magargal LE, Brown GC, Augsburger JJ, Parrish RK II (1981) Neovascular glaucoma following central retinal vein obstruction. Ophthalmology 88(11):1095–1101 - DOI
-
- Paul C, Sengupta S, Choudhury S, Banerjee S, Sleath BL (2016) Prevalence of glaucoma in Eastern India: the Hooghly River glaucoma study. Indian J Ophthalmol 64(8):578–583. https://doi.org/10.4103/0301-4738.191497 - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources